These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9928916)
1. Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers. Schlösser R; Röschke J; Rossbach W; Benkert O Eur Neuropsychopharmacol; 1998 Dec; 8(4):273-8. PubMed ID: 9928916 [TBL] [Abstract][Full Text] [Related]
2. Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects. Röschke J; Kögel P; Schlösser R; Wagner P; Mann K; Rossbach W; Benkert O Psychopharmacology (Berl); 1997 Jul; 132(1):44-9. PubMed ID: 9272758 [TBL] [Abstract][Full Text] [Related]
3. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216 [TBL] [Abstract][Full Text] [Related]
4. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men. Wilson S; Højer AM; Buchberg J; Areberg J; Nutt DJ J Psychopharmacol; 2015 Oct; 29(10):1085-91. PubMed ID: 26253622 [TBL] [Abstract][Full Text] [Related]
5. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine. Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030 [TBL] [Abstract][Full Text] [Related]
6. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers. Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185 [TBL] [Abstract][Full Text] [Related]
7. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Feige B; Voderholzer U; Riemann D; Dittmann R; Hohagen F; Berger M Neuropsychopharmacology; 2002 Feb; 26(2):246-58. PubMed ID: 11790520 [TBL] [Abstract][Full Text] [Related]
8. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J Sleep; 1995 Jul; 18(6):470-7. PubMed ID: 7481419 [TBL] [Abstract][Full Text] [Related]
9. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ Eur Neuropsychopharmacol; 2004 Oct; 14(5):367-72. PubMed ID: 15336297 [TBL] [Abstract][Full Text] [Related]
10. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Bell C; Wilson S; Rich A; Bailey J; Nutt D Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263 [TBL] [Abstract][Full Text] [Related]
11. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938 [TBL] [Abstract][Full Text] [Related]
12. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Kraiczi H; Hedner J; Dahlöf P; Ejnell H; Carlson J Sleep; 1999 Feb; 22(1):61-7. PubMed ID: 9989366 [TBL] [Abstract][Full Text] [Related]
13. Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers. Schlösser R; Wetzel H; Dörr H; Rossbach W; Hiemke C; Benkert O Psychoneuroendocrinology; 2000 May; 25(4):377-88. PubMed ID: 10725614 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878 [TBL] [Abstract][Full Text] [Related]
15. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894 [TBL] [Abstract][Full Text] [Related]
16. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078 [TBL] [Abstract][Full Text] [Related]
17. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692 [TBL] [Abstract][Full Text] [Related]
18. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Murck H; Nickel T; Künzel H; Antonijevic IA; Schill J; Zobel A; Steiger A; Sonntag A; Holsboer F Neuropsychopharmacology; 2003 Feb; 28(2):348-58. PubMed ID: 12589388 [TBL] [Abstract][Full Text] [Related]
19. Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains. Kostyalik D; Vas S; Kátai Z; Kitka T; Gyertyán I; Bagdy G; Tóthfalusi L BMC Neurosci; 2014 Nov; 15():120. PubMed ID: 25406958 [TBL] [Abstract][Full Text] [Related]
20. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ Br J Psychiatry; 2002 Jun; 180():528-35. PubMed ID: 12042232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]